A New Emerging Risk Factor for Cardiovascular Disease: Apo(a) Polymorphism

Publisher： Karger

E-ISSN： 1424-0556|3|3|159-163

ISSN： 1422-9528

Source： Heart Drug, Vol.3, Iss.3, 2003-11, pp. : 159-163

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Chronic obstructive pulmonary disease: a novel risk factor for cardiovascular disease

By Sin Don D   Man S.F P.  

Canadian Journal of Physiology and Pharmacology, Vol. 83, Iss. 1, 2005-01 ,pp. : 8-13

NRC Research Press

Access to resources Recommend Favorite

Chlamydia pneumoniae: risk factor for cardiovascular disease?

By  

Inpharma, Vol. 1, Iss. 1368, 2002-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Asymmetric Dimethylarginine: a Novel Cardiovascular Risk Factor in End-stage Renal Disease

By Alsagaff M Yusuf   Thaha M   Aminuddin M   Yogiarto RM   Yogiantoro M   Tomino Y  

The Journal of International Medical Research, Vol. 40, Iss. 1, 2012-01 ,pp. : 340-349

Field House Publishing

Access to resources Recommend Favorite

Hyperglycemia: An Upcoming Major Global Risk Factor for Cardiovascular Disease

By  

Heart Drug, Vol. 4, Iss. 4, 2004-12 ,pp. : 175-176

Karger

Access to resources Recommend Favorite

Group II Secretory PLA2: A New Cardiovascular Risk Factor

By  

Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Inflammatory and Anti-Allergy Agents), Vol. 5, Iss. 2, 2006-05 ,pp. : 163-173

Bentham Science Publishers

Access to resources Recommend Favorite